The ELTSL is expected to accumulate selectively in the tumour through the enhanced permeability and retention effect, and then subsequently strip the PEG corona through MMP-2-mediated cleavage of peptide spacer for deeper penetration inside the tumour. The gene discussed is MMP2; the disease is neoplasm.